Transcriptional control of a stem cell factor nucleostemin in liver regeneration and aging.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 23 05 2024
accepted: 27 08 2024
medline: 11 9 2024
pubmed: 11 9 2024
entrez: 11 9 2024
Statut: epublish

Résumé

Nucleostemin (NS) plays a role in liver regeneration, and aging reduces its expression in the baseline and regenerating livers following 70% partial hepatectomy (PHx). Here we interrogate the mechanism controlling NS expression during liver regeneration and aging. The NS promoter was analyzed by TRANSFAC. Functional studies were performed using cell-based luciferase assay, endogenous NS expression in Hep3B cells, mouse livers with a gain-of-function mutation of C/EBPα (S193D), and mouse livers with C/EBPα knockdown. We found a CAAT box with four C/EBPα binding sites (-1216 to -735) and a GC box with consensus binding sites for c-Myc, E2F1, and p300-associated protein complex (-633 to -1). Age-related changes in NS expression correlated positively with the expression of c-Myc, E2F1, and p300, and negatively with that of C/EBPα and C/EBPβ. PHx upregulated NS expression at 1d, coinciding with an increase in E2F1 and a decrease in C/EBPα. C/EBPα bound to the consensus sequences found in the NS promoter in vitro and in vivo, inhibited its transactivational activity in a binding site-dependent manner, and decreased the expression of endogenous NS in Hep3B cells. In vivo activation of C/EBPα by the S193D mutation resulted in a 4th-day post-PHx reduction of NS, a feature shared by 16-m/o livers. Finally, C/EBPα knockdown increased its expression in aged (24-m/o) livers under both baseline and regeneration conditions. This study reports the C/EBPα suppression of NS expression in aged livers, providing a new perspective on the mechanistic orchestration of tissue homeostasis in aging.

Identifiants

pubmed: 39259742
doi: 10.1371/journal.pone.0310219
pii: PONE-D-24-19975
doi:

Substances chimiques

Nuclear Proteins 0
GTP-Binding Proteins EC 3.6.1.-
Proto-Oncogene Proteins c-myc 0
CCAAT-Enhancer-Binding Protein-beta 0
E2F1 Transcription Factor 0
nucleostemin protein, mouse 0
E1A-Associated p300 Protein EC 2.3.1.48
CCAAT-Enhancer-Binding Protein-alpha 0
Carrier Proteins 0
E2f1 protein, mouse 0
Ep300 protein, mouse EC 2.3.1.48
RNA-Binding Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0310219

Informations de copyright

Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

he authors have declared that no competing interests exist.

Auteurs

Xiaoqin Liu (X)

Institute of Biosciences and Technology, Texas A&M Health, Houston, TX, United States of America.
Department of Translational Medical Sciences, Texas A&M University School of Medicine, Bryan, TX, United States of America.

Junying Wang (J)

Institute of Biosciences and Technology, Texas A&M Health, Houston, TX, United States of America.

Fang Li (F)

Institute of Biosciences and Technology, Texas A&M Health, Houston, TX, United States of America.

Nikolai Timchenko (N)

Department of Surgery, Cincinnati Children Hospital Medical Center, University of Cincinnati, Cincinnati, OH, United States of America.

Robert Y L Tsai (RYL)

Institute of Biosciences and Technology, Texas A&M Health, Houston, TX, United States of America.
Department of Translational Medical Sciences, Texas A&M University School of Medicine, Bryan, TX, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH